Skip to content
Medical Health Aged Care

Novotech Named a Fierce CRO Award Winner in the Excellence in Clinical Trial Management and Global Operations Categories

Novotech 3 mins read
SYDNEY--BUSINESS WIRE--

Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and novel therapeutics, today announced it was named a Fierce CRO Award winner by Fierce Biotech in the Clinical Trial Management and Global Operations categories.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241216597492/en/

Clinical Trial Management Award for Novotech (Graphic: Business Wire)

Clinical Trial Management Award for Novotech (Graphic: Business Wire)

“We’re grateful for this recognition, which is a direct result of our team’s effort and commitment to our mission,” said Novotech CEO Dr. John Moller. “It’s a reminder of what we can accomplish when we work together, and we look forward to continuing this momentum.”

The Fierce CRO Awards celebrate exceptional achievements and innovations by Contract Research Organizations (CROs). These awards honor CROs that have demonstrated outstanding performance, innovation, and leadership in delivering high-quality research and development services. By recognizing the excellence of CROs, the awards aim to highlight the critical role they play in advancing life sciences research and improving patient outcomes.

“The Fierce CRO Awards recognize and celebrate the remarkable achievements of Contract Research Organizations in the life sciences industry,” said Rebecca Willumson, SVP and Publisher of Fierce Biotech and Fierce Pharma. “This inaugural program showcases an elite class working to advance research and development and further the industry as a whole.”

This is the inaugural year of the Fierce CRO Awards. Award winners were judged on: Innovation and Impact, Measurable Outcomes, Sustainability and Scalability, and Ethical and Regulatory Adherence.

Winners are featured in the Fierce CRO Report. Click here to read the report.

About Novotech

Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech and small to mid size pharma companies to accelerate the development of advanced and novel therapeutics at every phase.

Recognized for its industry-leading contributions, Novotech has received numerous prestigious awards, including the Frost & Sullivan 2024 Global Biotech CRO Award, 2024 Clinical Trials Arena Award for Excellence in Business Expansion, Marketing, and Innovation,  2024 Employer of Choice, 2024 Great Place to Work in the US, 2024 Brandon Hall Gold Award, CRO Leadership Award 2023, the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence 2023, the Asia-Pacific Contract Research Organization Company of the Year Award since 2006.

The Company offers a comprehensive suite of services including laboratories, Phase I facilities, drug development consulting, regulatory expertise, and has experience with over 5,000 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. With a presence in 34 office locations and a dedicated team of 3,000+ professionals worldwide, Novotech is a trusted end-to-end strategic partner of choice.

For more information or to speak to an expert team member visit www.Novotech-CRO.com

About Fierce Biotech

Fierce Biotech is the biotech industry's daily monitor, providing the latest news, articles, and resources related to clinical trials, drug discovery, FDA approval, FDA regulation, patent news, pharma news, biotech company news and more. More than 300,000 top biotech professionals rely on Fierce Biotech for an insider briefing on the day's top stories.


Contact details:

Media
Toyna Chin
mediacontact@novotech-cro.com
USA: +1 415 364 8135

Media

More from this category

  • Medical Health Aged Care
  • 17/01/2025
  • 10:12
Dementia Australia

Country music singer Adam Harvey appointed Dementia Australia Ambassador in honour of his mother

Dementia Australia welcomes renowned country music singer and songwriter Adam Harvey as its newest Ambassador, coinciding with his headline performances at the Tamworth Country Music Festival. Adam, a nine-time Golden Guitar Award winner, has a deeply personal connection to dementia. His mother’s diagnosis inspired him to write his heartfelt song, Remember Me, which he will perform this weekend. Through his music and platform, Adam hopes to bring greater awareness to dementia and its impact on families across Australia. “My mum’s journey with dementia has been deeply challenging for my family, but it has also shown me the importance of understanding,…

  • Contains:
  • Medical Health Aged Care, Sport Recreation
  • 17/01/2025
  • 08:40
Breast Cancer Network Australia

World-First Data: Supervised exercise program for people with incurable breast cancer reveals significant health and economic benefits.

17January, 2025 A world-first study has revealed that two hours of supervised exercise per week significantly benefits people with metastatic breast cancer, improving quality of life while reducing healthcare costs. The PREFERABLE-EFFECT trial, involving 357 participants worldwide, including 135 Australians, is the most extensive exercise study conducted for this population. Participants completed a nine-month program of supervised aerobic, resistance, and balance exercises twice a week, compared to those following general activity advice. Participants in the supervised exercise program experienced significant improvements in quality of life, with reductions in debilitating symptoms such as fatigue, pain, and emotional distress, enabling them to…

  • Medical Health Aged Care
  • 17/01/2025
  • 01:40
King Faisal Specialist Hospital & Research Centre

King Faisal Specialist Hospital and Research Centre Performs the World’s First Robotic-Assisted Artificial Heart Pump Implantation

RIYADH, Saudi Arabia, Jan. 16, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed the world’s first robotic-assisted implantation of an artificial heart pump (HeartMate 3) developed by Abbott, a groundbreaking procedure that marks a significant advancement in medical technology and patient care.The surgery was performed on a 35-year-old man who had been hospitalized for 120 days due to advanced heart failure, which had also led to kidney and lung function deterioration. Thanks to this innovative surgical procedure, the patient is now on track to fulfill his dream of returning home to…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.